Dr Peter Prinsloo MB ChB, FRCP, FRCPath - Head of Clinical Governance

GMC registration: 4135474

Dr Peter Prinsloo is our head of clinical governance and makes sure that we meet and exceed the highest standards in quality and governance. Peter joined the team in 2017 as a reporting doctor after admiring Medichecks' high level of ethical responsibility.

Peter studied medicine in Pretoria and Cape Town, South Africa, and completed his postgraduate training in the UK. After that, he studied chemical pathology to work within laboratory and clinical settings – allowing him to be part of cutting-edge scientific developments.

Outside of Medichecks, Peter is a consultant chemical pathologist at an NHS teaching hospital and specialises in cardiovascular risk, metabolic bone diseases and general diagnostics. Peter enjoys the variety that comes through combining clinical practice with laboratory responsibility.

We asked Peter what he enjoys about Medichecks.

Dr Peter Prinsloo:

“There is no doubt that at-home health tests will continue to expand over the next few years and empower people to take control of their health and wellbeing. In my view, Medichecks’ passion to provide timely and quality results, with the added value of its high standard reports, allows customers the opportunity to understand more about their health and make informed changes.

“I enjoy both the fact that everyone at Medichecks works towards a common goal and the lively and open discussions we have. The enthusiasm of the senior management team and professionalism of support and services teams means we always strive to get good quality results out as soon as possible.

“Outside of practising and reporting, I enjoy spending time outdoors - either gardening or exploring the countryside. I also enjoy travelling, although this has been very much restricted during the pandemic years. Always keen to learn and contribute, I’ve published a small number of papers in peer-reviewed journals and presented at national and international conferences on topics including the quality of laboratory reporting, cost control within laboratories and the management of osteoporosis.”